Cargando…

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

The RNA virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Cell entry is mediated by the human angiotensin-converting enzyme II (ACE2). ACE2 and its close homolog angiotensin-converting enzyme I (ACE) are currently discussed can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möhlendick, Birte, Schönfelder, Kristina, Breuckmann, Katharina, Elsner, Carina, Babel, Nina, Balfanz, Paul, Dahl, Edgar, Dreher, Michael, Fistera, David, Herbstreit, Frank, Hölzer, Bodo, Koch, Michael, Kohnle, Matthias, Marx, Nikolaus, Risse, Joachim, Schmidt, Karsten, Skrzypczyk, Sarah, Sutharsan, Sivagurunathan, Taube, Christian, Westhoff, Timm H., Jöckel, Karl-Heinz, Dittmer, Ulf, Siffert, Winfried, Kribben, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415730/ https://www.ncbi.nlm.nih.gov/pubmed/34001841 http://dx.doi.org/10.1097/FPC.0000000000000436

Ejemplares similares

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study
por: Schönfelder, Kristina, et al.
Publicado: (2021)

The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
por: Möhlendick, Birte, et al.
Publicado: (2022)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
por: Čiučiulkaitė, Ieva, et al.
Publicado: (2022)

Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in IFITM3 on the Antibody Response after Vaccination against COVID-19
por: Čiučiulkaitė, Ieva, et al.
Publicado: (2023)

Development of De Novo Donor-specific HLA Antibodies and AMR in Renal Transplant Patients Depends on CYP3A5 Genotype
por: Friebus-Kardash, Justa, et al.
Publicado: (2021)

GNB3 c.825C>T (rs5443) Polymorphism and Risk of Acute Cardiovascular Events after Renal Allograft Transplant
por: Peitz, Tobias, et al.
Publicado: (2022)

CC Genotype of GNAS c.393C>T (rs7121) Polymorphism Has a Protective Effect against Development of BK Viremia and BKV-Associated Nephropathy after Renal Transplant
por: Peitz, Tobias, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism in Genes Encoding G Protein Subunits GNB3 and GNAQ Increase the Risk of Cardiovascular Morbidity among Patients Undergoing Renal Replacement Therapy
por: Birkner, Simon, et al.
Publicado: (2023)

Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany
por: Seidel, Maximilian, et al.
Publicado: (2020)

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia
por: Kattner, Simone, et al.
Publicado: (2023)

Wellenreiten – 12 Monate COVID-19 im Maximalversorger
por: Fistera, David, et al.
Publicado: (2021)

Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T – a case report
por: Welsner, Matthias, et al.
Publicado: (2019)

Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center
por: Buechter, Matthias, et al.
Publicado: (2023)

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
por: Bertram, Sebastian, et al.
Publicado: (2022)

Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care
por: Welsner, Matthias, et al.
Publicado: (2019)

How personality influences health outcomes and quality of life in adult patients with cystic fibrosis
por: Niehammer, Ute, et al.
Publicado: (2023)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
por: Seibert, Felix S., et al.
Publicado: (2022)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
por: Niehammer, Ute, et al.
Publicado: (2022)

beadplexr: reproducible and automated analysis of multiplex bead assays
por: Stervbo, Ulrik, et al.
Publicado: (2018)

Vaccination in patients with kidney failure: lessons from COVID-19
por: Babel, Nina, et al.
Publicado: (2022)

Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019
por: Doevelaar, Adrian A. N., et al.
Publicado: (2023)

Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis Patients
por: Anft, Moritz, et al.
Publicado: (2023)

Immunogenicity of Bivalent Omicron BA.4/5–Adapted Vaccine in Hemodialysis Patients
por: Anft, Moritz, et al.
Publicado: (2023)

Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV‐2 antibodies
por: Bertram, Sebastian, et al.
Publicado: (2022)

Trainability of Health-Related and Motor Performance Fitness in Adults with Cystic Fibrosis within a 12-Month Partially Supervised Exercise Program
por: Welsner, Matthias, et al.
Publicado: (2021)

Lessons for the clinical nephrologist: recurrence of nephrotic syndrome induced by SARS-CoV-2
por: Doevelaar, Adrian A. N., et al.
Publicado: (2020)

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy
por: Westhölter, Dirk, et al.
Publicado: (2023)

SARS‐CoV‐2 rapid antigen test: Fast‐safe or dangerous? An analysis in the emergency department of an university hospital
por: Holzner, Carola, et al.
Publicado: (2021)

What about the others: differential diagnosis of COVID-19 in a German emergency department
por: Fistera, David, et al.
Publicado: (2021)

Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
por: Straßburg, Svenja, et al.
Publicado: (2022)

Effects of a Long-Term Monitored Exercise Program on Aerobic Fitness in a Small Group of Children with Cystic Fibrosis
por: Gruber, Wolfgang, et al.
Publicado: (2022)

Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins
por: Stervbo, Ulrik, et al.
Publicado: (2020)

Longitudinal Changes of Cytokines and Appetite in Older Hospitalized Patients
por: Pourhassan, Maryam, et al.
Publicado: (2021)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Risikomanagement in der Triage ambulanter Notfallpatienten: Manchester Triage System und CEReCo-blue als Instrument zur risikoarmen Patientensteuerung in integrierten Notfallzentren
por: Pabst, Dirk, et al.
Publicado: (2021)

Point-of-care PCR testing of SARS-CoV-2 in the emergency department: Influence on workflow and efficiency
por: Fistera, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8q5i5pc0s1humaaeo2mt0l8h5h